Literature DB >> 32285830

The effect of the presence of epileptic attacks on the clinical duration of supratentorial brain meningiomas.

Taras О Studeniak1, Volodymyr І Smolanka1, Olesya I Borovik1.   

Abstract

OBJECTIVE: The aim: To study the effect of epileptic seizures in patients with supratentorial brain meningiomas on the clinical course of meningiomas in the early and late postoperative period. PATIENTS AND METHODS: Materials and methods: A retrospective analysis of the course of the disease was performed in 242 patients with total removed supratentorial meningioma of the brain (general group). Long-term outcome of the disease was estimated in 176 people (a catamnesis group).
RESULTS:
Results: The occurrence of a new neurological deficit was observed in 18 (18.0±3.8 %) patients out of 100 among patients with epileptic seizures before surgery and in 19 (13.4±2.9 %) out of 142 among those who had no seizures. The mortality rate was 1 (1.0±1.0 %) in the group of patients with seizures and 3 (2.8±1.4 %) in the group of patients without seizures before surgery. The prevalence of new neurological deficits in the catamnesis group is 14 (19.2±4.6 %) of 73 patients with epileptic seizures before surgery and 17 (16.5±3.7 %) of 103 patients without seizures. Mortality was 3 cases (4.1±2.3 %) in patients with seizures and 9 cases (8.7±2.8 %) among patients without seizures.
CONCLUSION: Conclusions: No data have been obtained that the presence of epileptic seizures affects the incidence of new neurological deficits, complications and mortality after surgical treatment of meningiomas in the early and late postoperative period.

Entities:  

Keywords:  Epilepsy; long-term follow-up ; meningioma; seizure

Mesh:

Year:  2020        PMID: 32285830

Source DB:  PubMed          Journal:  Wiad Lek        ISSN: 0043-5147


  1 in total

1.  Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study.

Authors:  Erik Thurin; Isabelle Rydén; Thomas Skoglund; Anja Smits; Sasha Gulati; Göran Hesselager; Jiri Bartek; Roger Henriksson; Øyvind Salvesen; Asgeir S Jakola
Journal:  Cancer Med       Date:  2021-03-26       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.